Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of clostridium difficile spores

Infection Control and Hospital Epidemiology

Volumn 30, Issue 6, 2009, Pages 507-514

  Barbut, F ^a   Menuet, D ^a   Verachten, M ^b   Girou, E ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; UNCLASSIFIED DRUG; VINYL CHLORIDE; VINYLPOLYCHLORIDE;

ARTICLE; BACTERIAL COUNT; BACTERIAL SPORE; BACTERIUM CONTAMINATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISINFECTION; DRUG EFFICACY; DRY MIST DISINFECTION; ERADICATION THERAPY; FRANCE; FURNITURE; HOSPITAL; HUMAN; IN SITU HYBRIDIZATION; IN VITRO STUDY; MULTICENTER STUDY; PLATE COUNT; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RANDOMIZED CONTROLLED TRIAL; WASTE MANAGEMENT;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DISINFECTANTS; DISINFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENVIRONMENTAL MICROBIOLOGY; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; HYDROGEN PEROXIDE; INFECTION CONTROL; PATIENTS' ROOMS; SODIUM HYPOCHLORITE; SPORES, BACTERIAL; TREATMENT OUTCOME; VOLATILIZATION;

EID: 67651089832     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/597232     Document Type: Article

References (34)

1. Barbut F, Petit JC. Epidemiology of Clostridium difficile- associated infections. Clin Microbiol Infect 2001; 7:405-410.
2. Bartlett JG. Narrative review: the new epidemic of Clostridium difficileassociated enteric disease. Ann Intern Med 2006; 145:758-764.
3. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204- 210.
4. Loo VG, Poirier L, Miller MA, Oughton M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-2449.
5. McDonald LC., Killgore GE, Thompson A, et al. An epidemiC., toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433- 2441.
6. Coignard B, Barbut F, Blanckaert K, et al. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill 2006; 11:E060914 1.
7. Réseau d'Alerte d'Investigation et de Surveillance des Infections Nosocomiales. Conduite à tenir: diagnostiC., surveillance, investigation, prévention et contrô le des infections à Clostridium difficile. Saint-Maurice, France: Institut de Veille Sanitaire, 2006
8. Kuijper E, Barbut F, Brazier J, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Euro Surveill 2008; 13:31.
9. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42-50.
10. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC., Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45:992-998.
11. Akerlund T, Persson I, Unemo M, et al. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J Clin Microbiol 2008; 46: 1530-1533.
12. Fawley WN, Underwood S, Freeman J, et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 2007; 28:920-925.
13. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003; 54:109-114.
14. Dubberke E, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infection in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (supp 1):S81-S92.
15. Andersen BM, Rasch M, Hochlin K, Jensen FH, Wismar P, Fredriksen JE. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect 2006; 62: 149-155.
16. Shapey S, Machin K, Levi K, Boswell TC. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect 2008; 70:136-141.
17. Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 2009; 47:205-207.
18. Johnston MD, Lawson S, Otter JA. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005; 60:403- 411.
19. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000; 31:995-1000.
20. Vonberg RP, Kuijper EJ, Wilcox MH, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008;14(suppl 5):2-20.
21. Majcher MR, Bernard KA, Sattar SA. Identification by quantitative carrier test of surrogate spore-forming bacteria to assess sporicidal chemicals for use against Bacillus anthracis. Appl Environ Microbiol 2008; 74:676-681.
22. Wullt M, Odenholt I, Walder M. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003; 24:765-768.
23. Verity P, Wilcox MH, Fawley W, Parnell P. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 2001; 49:204-209.
24. Samore MH, Venkataraman L, DeGirolami PC., Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32-40.
25. Eckstein BC., Adams DA, Eckstein EC., et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007; 7:61.
26. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127:1289-1294.
27. McMullen KM, Zack J, Coopersmith CM, Kollef M, Dubberke E,Warren DK. Use of hypochlorite solution to decrease rates of Clostridium difficile- associated diarrhea. Infect Control Hosp Epidemiol 2007; 28:205-207.
28. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med 2007; 167:1092-1097.
29. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000; 356:1324.
30. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007; 65(suppl 2):50-54.
31. Boyce JM, Havill NL, Otter JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008; 29:723-729.
32. Otter JA, French GL, Adams NM, Watling D, Parks MJ. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006; 62:384-385.
33. Omidbakhsh N, Sattar SA. Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am J Infect Control 2006; 34:251-257.
34. Perez J, Springthorpe VS, Sattar SA. Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. Am J Infect Control 2005; 33:320-325.